中国CT和MRI杂志
中國CT和MRI雜誌
중국CT화MRI잡지
CHINESE JOURNAL OF CT AND MRI
2015年
5期
91-93
,共3页
黄裕存%曹治%邝宇良%陆少范%黄胜福
黃裕存%曹治%鄺宇良%陸少範%黃勝福
황유존%조치%광우량%륙소범%황성복
螺旋CT%间接淋巴造影%多期%增强扫描%胃癌%前哨淋巴结
螺鏇CT%間接淋巴造影%多期%增彊掃描%胃癌%前哨淋巴結
라선CT%간접림파조영%다기%증강소묘%위암%전초림파결
Spiral CT%Indirect Lymphography%Multi Phase Enhanced Scan%Gastric Cancer%Sentinel Lymph Node
目的:从多中心搜集资料,研究螺旋CT间接淋巴造影及多期增强扫描评估胃癌前哨淋巴结的方法及意义。方法2012年6月到2014年6月珠海市第五人民医院影像科采集数据。从无胃癌T0(50例)、cT1-2病人(35男29女)取得SLN标本。SLN影像检查和活检和随后的腹腔镜胃切除术、剖腹胃全切术及胃部分切除术均在珠海市第五人民医院进行。所有研究对象行螺旋CT间接淋巴造影技术及多期增强扫描。结果 T0、Tis、T1、T2、T3之间,间接淋巴造影、多期增强扫描、间接淋巴造影+多期增强扫描、活检四种方法的检出人数没有差异。T4时,间接淋巴造影检出51例(62.96%),多期增强扫描检出61例(75.30%),间接淋巴造影+多期增强扫描检出81例(100.0%),X2=9.271, P=0.000。N1、N2在间接淋巴造影、多期增强扫描、间接淋巴造影+多期增强扫描、活检四种方法的检出人数均有统计学差异(P<0.05)。N1四种方法的X2是:6.262,N2四种方法的X2是:3.199。螺旋CT三期增强扫描比间接CT淋巴结造影检出率高,X2=8,.482,P=0.000。结论采用螺旋CT间接淋巴造影技术及多期增强扫描对胃癌前哨淋巴结作出术前判断,可为胃癌前哨淋巴节清扫提供术前及术中依据,为胃癌微创手术临床应用打下基础,准确的胃癌分期诊断及淋巴结累及情况的判断也为手术提供影像学参考,从而达到胃癌合理临床手术治疗。
目的:從多中心搜集資料,研究螺鏇CT間接淋巴造影及多期增彊掃描評估胃癌前哨淋巴結的方法及意義。方法2012年6月到2014年6月珠海市第五人民醫院影像科採集數據。從無胃癌T0(50例)、cT1-2病人(35男29女)取得SLN標本。SLN影像檢查和活檢和隨後的腹腔鏡胃切除術、剖腹胃全切術及胃部分切除術均在珠海市第五人民醫院進行。所有研究對象行螺鏇CT間接淋巴造影技術及多期增彊掃描。結果 T0、Tis、T1、T2、T3之間,間接淋巴造影、多期增彊掃描、間接淋巴造影+多期增彊掃描、活檢四種方法的檢齣人數沒有差異。T4時,間接淋巴造影檢齣51例(62.96%),多期增彊掃描檢齣61例(75.30%),間接淋巴造影+多期增彊掃描檢齣81例(100.0%),X2=9.271, P=0.000。N1、N2在間接淋巴造影、多期增彊掃描、間接淋巴造影+多期增彊掃描、活檢四種方法的檢齣人數均有統計學差異(P<0.05)。N1四種方法的X2是:6.262,N2四種方法的X2是:3.199。螺鏇CT三期增彊掃描比間接CT淋巴結造影檢齣率高,X2=8,.482,P=0.000。結論採用螺鏇CT間接淋巴造影技術及多期增彊掃描對胃癌前哨淋巴結作齣術前判斷,可為胃癌前哨淋巴節清掃提供術前及術中依據,為胃癌微創手術臨床應用打下基礎,準確的胃癌分期診斷及淋巴結纍及情況的判斷也為手術提供影像學參攷,從而達到胃癌閤理臨床手術治療。
목적:종다중심수집자료,연구라선CT간접림파조영급다기증강소묘평고위암전초림파결적방법급의의。방법2012년6월도2014년6월주해시제오인민의원영상과채집수거。종무위암T0(50례)、cT1-2병인(35남29녀)취득SLN표본。SLN영상검사화활검화수후적복강경위절제술、부복위전절술급위부분절제술균재주해시제오인민의원진행。소유연구대상행라선CT간접림파조영기술급다기증강소묘。결과 T0、Tis、T1、T2、T3지간,간접림파조영、다기증강소묘、간접림파조영+다기증강소묘、활검사충방법적검출인수몰유차이。T4시,간접림파조영검출51례(62.96%),다기증강소묘검출61례(75.30%),간접림파조영+다기증강소묘검출81례(100.0%),X2=9.271, P=0.000。N1、N2재간접림파조영、다기증강소묘、간접림파조영+다기증강소묘、활검사충방법적검출인수균유통계학차이(P<0.05)。N1사충방법적X2시:6.262,N2사충방법적X2시:3.199。라선CT삼기증강소묘비간접CT림파결조영검출솔고,X2=8,.482,P=0.000。결론채용라선CT간접림파조영기술급다기증강소묘대위암전초림파결작출술전판단,가위위암전초림파절청소제공술전급술중의거,위위암미창수술림상응용타하기출,준학적위암분기진단급림파결루급정황적판단야위수술제공영상학삼고,종이체도위암합리림상수술치료。
Objective To evaluate the significance of spiral CT, indirect lymphography and multi phase enhanced scan on sentinel lymph node in gastric cancer.Methods The data were collected from the department of image in the Fifth People's Hospital of Zhuhai city during 2012 June to 2014June. SLN samples were obtained from the T0 of gastric cancer (50 cases), cT1-2patients (35 male and 29 female). All checks were performed in the Fifth People's Hospital of Zhuhai city, such as SLN imaging, biopsy and subsequent laparotomy laparoscopic gastrectomy, gastric partial hysterectomy and gastricresection. And all the patients were underwent spiral CT indirect lymphography and multi phase enhancement scanning.Results During the T0, Tis, T1, T2, T3 period, the detected number between indirect lymphography, multi phase enhanced scanning, indirect lymphography + multiphase enhanced scanning and biopsies had no difference. But during the T4 period, indirect lymphography detected 51 cases (62.96%), multi phase scan detected 61 cases (75.30%), indirect lymphography + multi phase scan detected 81 cases (100%), and there was significant difference between the four methods (X2=9.271, P=0.000). The detected number of N1, N2 in the four methods were statistically significant difference (P <0.05) , the X2 value were 6.262, 3.199 respectively. The detection rate of helical CT three phases enhanced images was higher than that used indirect CT lymphography (X2=8.482, P=0.000).Conclusion Spiral CT indirect lymphography and multi phase enhanced scan of sentinel lymph node in gastric cancer can help us make judgment and provide preoperative and intraoperative basis for sentinel gastric cancer sentinel lymph node cleaning,and lay the foundation for the clinical application of minimally invasive operation of gastric cancer. Meanwhile the accurate staging of gastric cancer and lymph node involvement judgment also provides image reference for operation, so as to achieve the reasonable operation of gastric cancer clinical treatment.